Browse By Tags - VetSurgeon.org

Related Tags

Results for Orthopaedics, Elanco

Vets urged to put OA treatment higher up the priority list

Arlo Guthrie

Osteoarthritis experts from the UK and the US came together at a roundtable event organised by Elanco late last year to discuss how canine osteoarthritis can be better managed, and have urged vets to put the disease higher up their priority list.

…
- over 8 years ago
- VetSurgeon.org
- VetSurgeon News
New video explains how to take the pain out of OA consultations

Arlo Guthrie

Elanco Animal Health, maker of Onsior, has created a new film in collaboration with Zoe Belshaw, an RCVS and European recognised internal medicine specialist, which offers tips to help engage owners on the subject of OA in their pet.

The company says…
- over 7 years ago
- VetSurgeon.org
- VetSurgeon News
Onsior gets new chronic pain indication in cats

Arlo Guthrie

Elanco has announced that Onsior 6 mg tablets have been licensed for the treatment of pain and inflammation associated with chronic musculoskeletal disorders in cats.

The NSAID's new indication is in addition to its existing license for acute pain and…
- over 7 years ago
- VetSurgeon.org
- VetSurgeon News
Elanco launches new canine osteoarthritis campaign

Arlo Guthrie

Elanco, the maker of Onsior, has launched a campaign to help practices educate owners about canine osteoarthritis.

Elanco says OA is a condition which is estimated to affect one in four dogs, but it is often labelled by owners as "just old age". This…
- over 7 years ago
- VetSurgeon.org
- VetSurgeon News
Elanco announces UK launch of new treatment for canine osteoarthritis pain

Arlo Guthrie

Elanco has announced that Galliprant (grapiprant), its new treatment for canine osteoarthritis pain, is now available in the UK.

Galliprant is a first in a class of drugs called piprants, or non-COX-inhibiting prostaglandin receptor antagonists (PRAs…
- over 7 years ago
- VetSurgeon.org
- VetSurgeon News